Handbook of Systemic Drug Treatment in Dermatology
portes grátis
Handbook of Systemic Drug Treatment in Dermatology
Wakelin, Sarah H.; Archer, Clive B.; Maibach, Howard I.
Taylor & Francis Ltd
02/2023
288
Mole
Inglês
9780367860813
15 a 20 dias
560
Descrição não disponível.
1. Acitretin. 2. Acne Antibiotics. 3. Alitretinoin 4. Antiandrogens. 5. Antibiotics Commonly Used for Skin Infections. 6. Antifungals. 7. Antimalarials. 8. Antivirals. 9. Apremilast. 10. Azathioprine. 11. Azole Antihelminths. 12. Bexarotene. 13. Ciclosporin. 14. Colchicine. 15. Corticosteroids. 16. Cyclophosphamide. 17. Dapsone. 18. Dimethyl Fumarate. 19. Interleukin 4/13 inhibitors. 20. Interleukin (IL)-12/23 and IL-23 Inhibitors. 21. Interleukin-17. antagonists. 22. Isotretinoin. 23. Ivermectin. 24. Intravenous Immunoglobulin. 25. Janus Kinase (JAK) Inhibitors. 26. Malignant Melanoma Drug Treatments. 27. Methotrexate. 28. Mycophenolate Mofetil. 29. Omalizumab. 30. Potassium Iodide. 31. Propranolol. 32. Psoralens. 33. Rituximab. 34. Sulfapyridine & Sulfamethoxy- pyridazine. 35. Thalidomide. 36. Tumour Necrosis Factor Antagonists. 37. Vismodegib. 38. Systemic Treatment in Children. 39. Kidney Disease. 40. Systemic Therapy & Liver Disease. 41. Systematic Therapy in Older People.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Drug therapy for skin diseases;Dermatology Drugs;Adverse Drug Effects;Adverse Drug Effects Dermatology;Important Drug Interactions;Advances in Drug Treatment;Drug Induced Liver Injury;Epidermolysis Bullosa Acquisita;Cutaneous Lupus Erythematosus;PASI;Chronic Actinic Dermatitis;Interferon Gamma Release Assays;IGRA;Severe Cutaneous Adverse Drug Reactions;Chronic Graft Versus Host Disease;Psoriatic Arthritis;HBV;Erythema Elevatum Diutinum;Hidradenitis Suppurativa;Benign Intracranial Hypertension;HBV Reactivation;Graft Versus Host Disease;IL-23 Inhibitor;Baseline PASI;Cutaneous Larva Migrans;Tinea Capitis;Oral Jak Inhibitor;Pre-filled Syringe;G6PD Deficiency;Childbearing Potential
1. Acitretin. 2. Acne Antibiotics. 3. Alitretinoin 4. Antiandrogens. 5. Antibiotics Commonly Used for Skin Infections. 6. Antifungals. 7. Antimalarials. 8. Antivirals. 9. Apremilast. 10. Azathioprine. 11. Azole Antihelminths. 12. Bexarotene. 13. Ciclosporin. 14. Colchicine. 15. Corticosteroids. 16. Cyclophosphamide. 17. Dapsone. 18. Dimethyl Fumarate. 19. Interleukin 4/13 inhibitors. 20. Interleukin (IL)-12/23 and IL-23 Inhibitors. 21. Interleukin-17. antagonists. 22. Isotretinoin. 23. Ivermectin. 24. Intravenous Immunoglobulin. 25. Janus Kinase (JAK) Inhibitors. 26. Malignant Melanoma Drug Treatments. 27. Methotrexate. 28. Mycophenolate Mofetil. 29. Omalizumab. 30. Potassium Iodide. 31. Propranolol. 32. Psoralens. 33. Rituximab. 34. Sulfapyridine & Sulfamethoxy- pyridazine. 35. Thalidomide. 36. Tumour Necrosis Factor Antagonists. 37. Vismodegib. 38. Systemic Treatment in Children. 39. Kidney Disease. 40. Systemic Therapy & Liver Disease. 41. Systematic Therapy in Older People.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Drug therapy for skin diseases;Dermatology Drugs;Adverse Drug Effects;Adverse Drug Effects Dermatology;Important Drug Interactions;Advances in Drug Treatment;Drug Induced Liver Injury;Epidermolysis Bullosa Acquisita;Cutaneous Lupus Erythematosus;PASI;Chronic Actinic Dermatitis;Interferon Gamma Release Assays;IGRA;Severe Cutaneous Adverse Drug Reactions;Chronic Graft Versus Host Disease;Psoriatic Arthritis;HBV;Erythema Elevatum Diutinum;Hidradenitis Suppurativa;Benign Intracranial Hypertension;HBV Reactivation;Graft Versus Host Disease;IL-23 Inhibitor;Baseline PASI;Cutaneous Larva Migrans;Tinea Capitis;Oral Jak Inhibitor;Pre-filled Syringe;G6PD Deficiency;Childbearing Potential
